Joyce Campbell – PESI – 2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice

Description

2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice download , Joyce Campbell – PESI – 2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice review, Joyce Campbell – PESI – 2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice free

Joyce Campbell – PESI – 2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice

• Strategies for intracranial pressure monitoring and lumbar drains
• Quick tips to advance your neuro assessment skills
• Neuro emergencies to keep on your radar
• Understand the newest drugs used to treat neurological disease
• Tools for maximizing time to needle for stroke
• Stroke and young women: The story of 3 lives
• Algorithms for diagnosing and treatment
• Hope through research

Over the past 20 years, I have witnessed dramatic changes in the care of patients with neurosurgical problems. I have moved from feeling helpless to extremely encouraged by what we can do for our patients. Technology and pharmaceuticals have altered the course of many of these diseases. Many of our old practices have been “put to pasture”. We will look beyond the basics and explore areas that are less known. Every day new and exciting research provides us with novel treatments. We will explore new drugs, promising interventions and evidence that is emerging into practice. My goal is to equip you with tools to better identify problems and improve overall care on the frontline. It is my aspiration that you will leave the seminar energized and better prepared to care for patients with neurological problems.

Joyce Campbell, MSN, SCRN, CCRN, FNP-C

Speaker
Joyce Campbell, MSN, CCRN, SCRN, FNP-BC, has been involved in the nursing field for 35 years. For over 25 years, she taught in an associate degree nursing program where her primary focus was the theory and clinical instruction of neuroscience nursing. In addition to teaching, she has been employed by Comprehensive Health System in Chattanooga, Tennessee for the past 30 years. At Erlanger, she has adopted many roles, including neurosurgical and trauma critical care staff nurse, educator and nurse practitioner. Currently, she serves on the neuroservice line committee and provides stroke education to staff and patients. Erlanger Southeast Regional Stroke Center, an accredited Primary Stroke Center, houses a leading-edge stroke care facility serving over 2000 stroke patients annually.

Through her work at Erlanger, Joyce is able to experience, first hand, the latest innovative strategies for extending the window of treatment for stroke patients. She holds a BSN from East Tennessee State University, an MSN from the University of Tennessee at Knoxville, and completed post-graduate studies at the University of Alabama at Birmingham. Joyce is an active member of the American Association of Critical Care Nurses, the American Association of Neuroscience Nurses, American Association of Nurse Practitioners, and the Chattanooga Association of Nurses in Advanced Practice, where she has served as president and is a member of the educational committee.

Speaker Disclosures:
Financial: Joyce Campbell has an employment relationship with Erlanger Southeast Regional Stroke Center. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Joyce Campbell is a member of the educational committee for the Chattanooga Association of Nurses in Advanced Practice.

Target Audience
Nurses, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, Physician Assistants, Speech-Language Pathologists
Objectives

1. Manage adult-onset neurological disorders with the latest treatments.
2. Determine optimal interventions based on neuro symptom presentation.
3. Evaluate when pharmacological and non-pharmacological options are recommended.
4. Dissect the very latest research for neurological disease.
5. Analyze the latest emerging neurological diseases.
6. Breakdown the procedure for intracranial monitoring.
7. Employ algorithms of care for neurological emergencies.
8. Correlate neuroanatomy to presenting clinical manifestations.
9. Provide guidelines for maximizing the neuro assessment.
10. Exploit common neuro problems occurring in degenerative diseases.
11. Communicate controversial issues relating to patient care.
12. Explore the latest information emerging on neurological diseases.

Outline

Toolbox for Assessment

• Simplifying neuro assessment through application of neuro anatomy
• Correlate pathophysiology with clinical manifestations
• NIHSS and GCS, brain death, Mini
• Mental, verbal fluency, memory, right and left hemisphere function, CAM assessment

Neurological Testing

• CT, CTA, arteriogram, MRI, perfusion

10 Leading Neurological Disorders

• Traumatic Brain Injury
• Updated recommendations for care
• Practical approaches for measuring IICP
• Research on neuroprotective agents

Stroke Patient

• Maximizing time to needle time for ischemic stroke
• The 5 D’s for identifying posterior stroke
• Wading through the clinical practice guidelines for blood pressure management in stroke patients
• Stroke and the young adult
• Expanding the window of care

Alzheimer’s Disease

• “Still Alice”: Mild, moderate and severe
• Treatment for cognitive and neuropsychiatric symptoms
• From “mice to men”: Hope is on the horizon
• Caregiver support

Epilepsy

• Seizure types and treatment
• Unprovoked seizure: Work-up and treatment decisions
• Status epilepticus

Parkinson’s Disease

• Traditional and alternative medicine treatment
• Deep brain stimulation

Brain Tumor

• Integrated care: Conventional treatments and supportive therapies

HIV

• Neurological manifestations
• Diagnostic work-up

Multiple Sclerosis

• Unpredictable disease of CNS
• Diagnostic criteria
• Current treatment practices

ALS

• Clinical manifestations; Diagnostic work up
• Assistive technology challenge
• Clinical trials

Emergent Neurological Disease: Zika and Guillain Barré

Commonalities and Unique Problems:

• Aphasia
• Dysarthria
• Dysphagia
• Visual problems
• Mobility
• Cognitive impairment
• Hemi-inattention
• Anosognosia
• Pseudobulbar affect (PBA)
• Spasticity
• Dizziness and vertigo
• Bowel and bladder dysfunction
• Sleep disturbances
• Depression
• Social isolation
• Caregiver fatigue

Pharmacological Therapy

• Osmotic diuretics
• Sedatives and pain medications
• Antispasmodic medications
• Antiseizure medications
• Antidepressants
• Medications to prevent and treat stroke
• Chemotherapy for brain tumors
• Disease modifying agents for MS
• Corticosteroids
• Medications to treat:
• Parkinson’s Disease
• Alzheimer’s DiseaseCommonly Asked Questions:
  1. Business Model Innovation: Acknowledge the reality of a legitimate enterprise! Our approach involves the coordination of a collective purchase, in which the costs are shared among the participants. We utilize this cash to acquire renowned courses from sale pages and make them accessible to individuals with restricted financial resources. Our clients appreciate the affordability and accessibility we provide, despite the authors’ concerns.
  2. 2-Day Neurological Challenges: New Medications & Promising Interventions to Change Practice Course
  • There are no scheduled coaching calls or sessions with the author.
  • Access to the author’s private Facebook group or web portal is not permitted.
  • No access to the author’s private membership forum.
  • There is no direct email support available from the author or their team.